Microbiology & parasitology
Atypical bacteria: Mycoplasma
M. pneumoniae


Topic Completed: 1 June 2020

Minor changes: 1 June 2020

Copyright: 2019-2020, PathologyOutlines.com, Inc.

PubMed Search: M. pneumoniae[TI]

Arthur H. Totten, Ph.D
Sixto M. Leal, Jr., M.D., Ph.D.
Page views in 2019: 6
Page views in 2020 to date: 147
Cite this page: Totten AH, Farr GA, Leal SM. M. pneumoniae. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/microbiologympneumoniae.html. Accessed August 11th, 2020.
Definition / general
  • Atypical bacterial pathogen, stained poorly by the dyes used in Gram stain due to the absence of a cell wall
  • Taxonomy: class Mollicutes, order Mycoplasmatales, family Mycoplasmataceae
Essential features
  • Common cause of community acquired pneumonia or walking pneumonia
  • No cell wall; does not Gram stain
  • Increasing rates of macrolide resistance (Clin Microbiol Rev 2017;30:747)
Epidemiology
  • Leading bacterial cause of community acquired pneumonia; ~ 2 million cases/year in the U.S. (Clin Microbiol Rev 2004;17:697)
  • Predominately affects children between 5 - 18 years old
  • Disseminated infections in immunocompromised individuals
  • Rapid spread via droplet contact and close community conditions (i.e. prisons, dormitories, barracks, etc.)
  • As immunity wanes, cyclic increases in infection rates occur ~ 3 - 7 years
Sites
  • Lung / atypical walking pneumonia (Clin Microbiol Rev 2017;30:747)
  • Throat / upper respiratory tract / tracheobronchitis
  • Disseminated infection
    • Central nervous system complications (encephalitis), dermatologic manifestations, joint infections, bacteremia
Pathophysiology
  • Adhesin, attachment to host cell vital for pathogenesis, initiation of infection (Clin Microbiol Rev 2004;17:697)
  • Community acquired respiratory distress syndrome toxin mediates acute infection (Clin Microbiol Rev 2017;30:747)
  • Lacks cell wall, therefore not susceptible to beta lactams
  • Lipoproteins are main immunogens for immunologic responses
  • Macrolide resistance increasing in U.S. (8 - 10%) and other parts of world (> 90% Japan, China), no widely known quinolone or tetracycline resistance reported
Clinical features
  • Usually associated with mild disease but can develop serious complications, such as pneumonia, asthma attacks, hemolytic anemia and other organ system involvement
  • Associated with I antigen positive on red blood cell cross match
  • Can lead to immune mediated sequelae including Stevens-Johnson syndrome, cold agglutinins (I antigen)
  • Coinfections are common (~ 20%); most commonly rhinovirus and enterovirus (N Engl J Med 2015;372:2167)
Laboratory
  • Does not stain on Gram stain
  • Requires special culture media which contain serum that provides fatty acids and cholesterol for mycoplasma membrane synthesis
  • Forms small, colorless, punctate colonies (dissection scope needed) on SP4 agar within 5 - 14 days when cultured aerobically at 37°C (Clin Microbiol Rev 2004;17:697)
  • Color change in liquid media due to glucose metabolism (red to yellow) is characteristic
  • PCR testing (nucleic acid amplification) required to differentiate from other glucose utilizing mycoplasmas
  • Serology testing performs poorly with respect to sensitivity and specificity (< 70 - 80%) for M. pneumoniae
    • When utilized, acute and convalescent sera are vital, as antibodies persist in previously exposed hosts
    • Acute sera is not sufficient for patient diagnosis
  • Combination of paired sera and others methods has been shown to be potentially useful in acute diagnosis but not as accurate or sensitive as molecular (e.g. PCR) based detection (Eur J Clin Microbiol Infect Dis 2011;30:439)
Case reports
Treatment
Clinical images

Contributed by Sixto M. Leal Jr., M.D., Ph.D.

SP4 broth for culture of M. pneumoniae

Representative colony photo of M. pneumoniae

Microscopic (histologic) description
  • M. pneumoniae is not visualized on H&E or other histologic stains (Carroll: Manual of Clinical Microbiology, 12th Edition, 2019)
  • 16S sequencing may be helpful to identify M. pneumoniae infection in FFPE tissues
  • Immunologic patterns consistent with infection include: acute peribronchial neutrophilic infiltrates and chronic lymphoplasmacytic inflammation with pneumocyte hyperplasia and intraalveolar proteinaceous material
  • Organisms can be visualized by electron microscopy
Molecular / cytogenetics description
Differential diagnosis
Board review style question #1
    A pediatric patient has presented to an outpatient clinic with persistent cough and fever. All typical microbiologic tests return no identifiable agent and empiric diagnosis with Mycoplasma pneumoniae is made. What is the main class of antibiotic for adequate treatment of this pathogen?

  1. Cephalosporins
  2. Macrolide
  3. Penicillin
  4. Tetracycline
Board review answer #1
B. Macrolides are the main means of treatment for M. pneumoniae in pediatric patients, as tetracyclines and quinolones are contraindicated in this patient population. Macrolide resistance is increasing and drug options may be limited in the near future.

Reference: M. pneumoniae

Comment Here
Board review style question #2
    A patient with immunodeficiency has reported pain in a knee joint and inflammation upon usage of the limb. Previous pulmonary infection had been reported without an identifiable pathogen on typical microbiologic media / culturing. Synovial fluid analysis additionally revealed no pathogens upon Gram stain analysis. What pathogen is the most likely cause of this disseminated infection?

  1. Chlamydia pneumoniae
  2. Clostridium perfringens
  3. Mycoplasma pneumoniae
  4. Staphylococcus aureus
Board review answer #2
C. Mycoplasma pneumoniae spreads from the lungs to various tissues, particularly in immunocompromised individuals, causing syndromes like septic arthritis. C. pneumoniae is rare and not known to cause significant systemic disease. C. perfringens and S. aureus would be detected as on Gram stain.

Reference: M. pneumoniae

Comment Here
Back to top